Integra Therapeutics to present ex vivo and in vivo data for its FiCAT gene writing platform at Advanced Therapies Europe congress

Advanced Therapies Europe - Avencia Sánchez Mejías

Integra Therapeutics will present positive data from ex vivo and in vivo preclinical studies that demonstrates the potential of its FiCAT gene writing platform for developing advanced therapies in the field of paediatric hepatology at the Advanced Therapies Europe congress, taking place in Estoril (Portugal) from 5 to 7 September. Dr Avencia Sánchez-Mejías, CEO and […]

Integra Therapeutics presents video ‘New FiCAT gene writing platform to cure diseases’

FiCAT gene writing platform

On 25 April, to celebrate DNA Day 2023, Integra Therapeutics launched a video explaining the new FiCAT gene writing platform developed by its scientific team. The video also explains the advances this entails in achieving more efficient and precise advanced therapies to cure patients through programmable DNA insertion to their genome. This year, DNA Day […]

Marc Güell wins the Spanish National Research Award for Young People 2022

Premios Nacionales de Investigación - Marc Güell

Dr Marc Güell has received the Ángela Ruiz Robles 2022 National Research Award for Young People, in the field of technology transfer, awarded by the Ministry of Science and Innovation of Spain. He was recognised for his contributions in harnessing synthetic biology to generate new basic principles of molecular biology for the design of biological […]

Integra Therapeutics and Caszyme receive €1-million Eurostars grant

Integra Therapeutics has been awarded €1-million grant from Eurostars, the largest funding programme of the European Commission that supports innovative SMEs in developing collaborative transnational projects geared towards the market. The company applied for the call as part of a consortium with Caszyme, a Lithuanian company that specialises in CRISPR technology and molecular tools development […]

Integra Therapeutics receives Catalan Society of Biology Award 2022

Integra Therapeutics has received the Catalan Society of Biology (SCB) Award for best innovative start-up of 2022 for developing the next-generation of gene writing tools for therapeutic purposes in the field of life sciences. The SCB Board of Directors recognised Integra Therapeutics’ innovative technology, the benefit to society and the team‘s ability to bring the […]

Marc Güell, new member of Young Academy of Spain

Dr Marc Güell, co-founder of Integra Therapeutics and principal investigator of the Translational Synthetic Biology Laboratory at Pompeu Fabra University (UPF), has been made a member of the Young Academy of Spain (AJE) after a selection process with 87 candidates. He will belong to the AJE for five years. This makes Dr Güell an Academic […]